Gut Check: How Your Intestinal Macrophages Could Be Key to Understanding Lupus
"Unlocking the secrets of mucosal immunity and its connection to systemic lupus erythematosus."
Monocytes, the body's first responders, play a crucial role in initiating immune responses against pathogens and managing inflammation. Once activated, these monocytes migrate to various tissue sites, transforming into macrophages that orchestrate both innate and adaptive immune reactions.
Within the gut, mucosal macrophages are vital. They typically produce anti-inflammatory cytokines, but disruptions in this process have been increasingly linked to autoimmune diseases like systemic lupus erythematosus (SLE).
This article delves into the function of human macrophages within the intestinal environment, focusing on their role in maintaining immune homeostasis and their potential involvement in the development of SLE. Further, the significance of sex differences in intestinal macrophages and their contribution to the physiology and pathogenesis of SLE will be highlighted.
What Role Do Intestinal Macrophages Play?

The gut's mucosal barrier, composed of the epithelium and lamina propria, is essential for maintaining overall health. Tight junctions between epithelial cells carefully regulate what enters the body. This barrier protects against harmful pathogens while allowing trace amounts of bacterial products to cross over, which is necessary to maintain systemic immune balance.
- CD14 and CD16 Expression: Human peripheral monocytes are categorized into subsets based on the presence of CD14 and CD16 markers.
- Classical Monocytes (CD14++CD16-): These are activated by Toll-like receptor (TLR) ligands like lipopolysaccharides (LPS). Once activated, they differentiate into macrophages or dendritic cells (DCs), releasing cytokines and migrating to tissues.
- Intermediate Monocytes (CD14++CD16+): Research indicates these are associated with cardiovascular diseases.
- Non-Classical Monocytes (CD14+CD16++): These monocytes primarily produce pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 when stimulated by TLR agonists. It is thought that they could be associated with autoimmune conditions.
The Future of Lupus Research
Macrophage-mediated tolerance and the prevention of pro-inflammatory responses to TLR ligands are essential for mucosal immunity. Altered TLR-mediated innate immune responses in intestinal macrophages may significantly contribute to SLE pathogenesis. Further studies could investigate how sex hormones affect intestinal macrophage function, gut mucosal immunity, and microbial translocation, thus improving SLE therapy.